GHK-Cu for Hair Growth: What the Research Shows (Australia)

GHK-Cu (Glycine-Histidine-Lysine complexed with copper ion) is a naturally occurring tripeptide found in human plasma, saliva, and urine. Its concentration declines significantly with age, from approximately 200 ng/mL at age 20 to around 80 ng/mL by age 60, a decline that coincides with the age-related reduction in the body's regenerative capacity.

In hair biology research specifically, GHK-Cu has attracted growing interest due to its effects on three distinct mechanisms relevant to hair follicle health: follicle enlargement, anagen phase prolongation, and angiogenesis. Unlike many compounds studied for hair applications, GHK-Cu has a published research base in both in-vitro cell models and human studies, making it one of the better-evidenced non-pharmaceutical options in the hair research space.

Search interest in GHK-Cu for hair applications has increased sharply in 2025–2026, driven by biohacking communities and longevity-focused content creators highlighting its regenerative profile.

One of the most cited GHK-Cu findings in hair research is its ability to increase hair follicle size. A key study by Pickart and colleagues demonstrated that GHK-Cu can enlarge hair follicles and stimulate hair growth in laboratory models.

The mechanism involves GHK-Cu's activation of follicle dermal papilla cells, the specialised cells at the base of each follicle that control follicle cycling and hair fibre diameter. Dermal papilla cells express copper-dependent metalloenzymes; copper availability influences their activity. GHK-Cu appears to support dermal papilla cell proliferation and signalling, leading to increased follicle size and thicker hair shaft production in preclinical models.

Follicle miniaturisation (the progressive shrinking of follicles into vellus (fine, unpigmented) hair) is the hallmark of androgenetic alopecia in both males and females. Research into compounds that reverse miniaturisation, including GHK-Cu, is therefore directly relevant to the study of pattern hair loss biology.

Hair follicles cycle through four phases: anagen (active growth), catagen (transition), telogen (resting), and exogen (shedding). The length of the anagen phase determines hair length potential, longer anagen means longer, denser hair before shedding.

Research has examined GHK-Cu's effects on TGF-β1 (Transforming Growth Factor beta-1), a signalling molecule that triggers the transition from anagen to catagen, effectively a "stop growing" signal. Studies have found that GHK-Cu can inhibit TGF-β1 activity in follicle cells, potentially prolonging the anagen phase and delaying premature entry into catagen.

This mechanism is distinct from the vasodilatory approach of compounds like minoxidil, and from the DHT-blocking approach of finasteride, suggesting GHK-Cu addresses a different pathway that could complement rather than duplicate existing research tools in hair follicle biology.

Hair follicles are among the most metabolically active structures in the body during the anagen phase, requiring substantial blood supply to sustain rapid keratinocyte proliferation and hair fibre production. GHK-Cu has documented pro-angiogenic activity, the promotion of new blood vessel formation, via upregulation of VEGF (vascular endothelial growth factor).

Research published across multiple studies demonstrates that GHK-Cu promotes angiogenesis in wound healing models. Applied to hair follicle biology, improved vascularity around the follicle bulb increases nutrient and oxygen delivery to the dermal papilla, creating a more favourable growth environment. This is the same mechanism by which scalp microneedling is believed to partially support hair density improvements, physical stimulation of VEGF and growth factor release. GHK-Cu may achieve a similar endpoint through a biochemical route.

The human evidence for GHK-Cu in hair applications is modest but more substantial than many peptides in this space:

• A 2018 study comparing topical copper peptide solution to placebo in subjects with androgenetic alopecia found statistically significant improvements in hair density and diameter in the treatment group after 6 months
• Multiple case reports and pilot studies from dermatology clinics report improved hair shaft diameter and reduced shedding with topical copper peptide preparations
• In-vitro studies on human dermal papilla cells consistently demonstrate GHK-Cu stimulates cell proliferation and upregulates hair growth-associated genes including VEGF and IGF-1

It is important to note that the majority of controlled human trials on GHK-Cu for hair use topical delivery systems rather than injectable peptide. The bioavailability and mechanistic differences between topical application and systemic or subcutaneous administration are not well characterised in published literature. Researchers investigating injectable GHK-Cu for hair biology are working in an area with limited direct human precedent but strong mechanistic rationale from preclinical data.

For researchers studying hair follicle biology, GHK-Cu occupies a distinct mechanistic niche compared to other commonly studied compounds:

GHK-Cu is also studied alongside IGF-1 LR3 in hair follicle models, as IGF-1 receptor signalling in dermal papilla cells interacts with GHK-Cu's growth factor pathways.

GHK-Cu is one of four compounds in the KLOW blend, alongside BPC-157, TB-500, and KPV. For researchers studying multi-pathway tissue regeneration and wanting to investigate GHK-Cu alongside complementary compounds, the KLOW vial offers a convenient single-reconstitution option.

For hair-specific research where GHK-Cu dose and administration need to be controlled independently, OzPeps stocks GHK-Cu as standalone vials in both 50mg and 100mg formats.

Research-grade GHK-Cu is available from OzPeps in two formats:

• GHK-Cu 50mg, standard research quantity
• GHK-Cu 100mg, extended research supply at lower per-mg cost

Both are supplied as lyophilised powder for reconstitution with bacteriostatic water. Fast Australia-wide shipping, discreet packaging. For the broader GHK-Cu research profile beyond hair applications, see the GHK-Cu general research guide →

All GHK-Cu products from OzPeps are supplied strictly for in-vitro laboratory and research purposes. Not TGA-approved. Not intended for human or animal consumption. Researchers are responsible for all applicable regulatory compliance.